ABSTRACT. The dehydrogenase/reductase (SDR family) member 4 (DHRS4) gene is copied during mammalian evolution; therefore, while only one DHRS4 gene is expressed in the mouse genome, the gene cluster consists of two (DHRS4 and DHRS4L1) and three (DHRS4, DHRS4L2, and DHRS4L1) copies in chimpanzees and humans, respectively. In this study, we explored the possible regulatory mechanism of the DHRS4 gene cluster in mammalian evolution by analyzing the promoter sequence, methylation of CpG islands, and RNA expression of the DHRS4 gene cluster in mice, chimpanzees, and humans by bioinformatics prediction, bisulfite sequencing PCR, and real-time reverse transcriptase-PCR. The results indicated that the DHRS4 gene was actively expressed in the three model species. The RNA level of DHRS4L1 was much lower than those of DHRS4 and DHRS4L2, and expressed lower homologous sequence identity to DHRS4 and DHRS4L2. DHRS4L2, the latest evolutionary copy of the DHRS4 gene in mammals, received a high promoter prediction score, and was the only copy of the DHRS4 gene cluster presenting hypermethylated CpG islands in the promoter region. An analysis of the relationship between the promoter characteristics and RNA expression of the DHRS4 gene cluster indicated that the development of CpG islands, in addition to the promoter sequence, during mammalian evolution could modulate the dose compensatory regulation of the copy number-varied DHRS4 gene cluster.
INTRODUCTION
The dehydrogenase/reductase member 4 gene (DHRS4) codes for short-chain dehydrogenase/reductases that participate in the retinoic acid, steroid, and xenobiotic carbonyl compounds in various species, associated with cell proliferation, differentiation, and tumorigenesis (Huang and Ichikawa, 1997; Matsunaga et al., 2008; Endo et al., 2009; Tang and Gudas, 2011) . Mammals such as mice, pigs, and members of the Canis family possess only one copy of the DHRS4 gene, while the chimpanzee genome harbors both the DHRS4 gene and its copy DHRS4L1. On the other hand, humans express a DHRS4 gene cluster comprising three homologous genes: DHRS4, DHRS4L2, and DHRS4L1 (Su et al., 2010) . The copied DHRS4 gene cluster is arranged in tandem in chromosome 14 of the chimpanzee and human genome.
Gene duplication is a major source of copy number variations in genes; additionally, gene duplication contributes to the development of complex functions to combat a variety of conditions in various species (Conant and Wolfe, 2008; Elliott et al., 2013) . For example, duplications or mutations in globulin reflect the metabolic demands and environmental oxygen availability during the different embryonic or post-birth life stages of an individual, or during the infection of erythrocytes by the malarial parasite (Lam and Jeffreys, 2006; Opazo et al., 2013) ; duplications in the AQP7 gene, which codes for a family of water-selective membrane channels, is representative of the adaptations in thermoregulation and energy utilization through biological transmembrane transport (Dumas et al., 2007) . Previous research has also suggested that mutations and duplications in the genes could also lead to the development of proteins that are harmful to the species; therefore, there is a high possibility that approximately 90% of the new copied genes is pseudogenized at the epigenetic level, affecting its functionality (Rodin and Riggs, 2003; Katju and Bergthorsson, 2013) . Therefore, the fate of the vast majority of gene duplications is detrimental, leading to its inhibition or removal by natural selection.
We have previously reported that the natural antisense transcript AS1DHS4 regulated the transcription of the DHRS4 gene cluster through the recruitment of histone modifiers and DNA methyltransferases to control DNA methylation, histone acetylation, and histone methylation in the promoter region of the human DHRS4 gene cluster . This led us to investigate the various modulations in the DHRS4 gene cluster in other species, containing different copy numbers of the DHRS4 gene, and the various factors involved in the regulatory process. In this study, we analyzed mouse, chimpanzee, and human cell lines presenting different DHRS4 gene copy numbers, to explore the transcriptional activity and possible transcription regulatory mechanism occurring in this gene during mammalian evolution, by bioinformatics analysis, reverse transcriptase quantitative PCR (RT-qPCR), and bisulfite sequencing PCR (BSP).
MATERIAL AND METHODS

Database and software
DNA and RNA sequences of the DHRS4 gene cluster in mice, chimpanzees, and humans were acquired from the National Center for Biotechnology Information (NCBI) GenBank (http://www.ncbi.nlm.nih.gov) database. The Jellyfish software and the online Basic Local Alignment Search Tool (BLAST) were adapted to analyze the homologous identity of DHRS4, DHRS4L2, and DHRS4L1. The promoter site and activity of the DHRS4 gene cluster were predicted by PROSCAN (http://www-bimas.cit.nih.gov/molbio/proscan/) (Prestridge, 1995 (Prestridge, , 2000 . Promoter cutoff score was set as 53, and the sequence of approximately 2000 bp from transcriptional start sites were provided for the software online.
The possible epigenetic regulatory mechanism occurring in the DHRS4 gene cluster was analyzed by investigating the status of the CpG islands in the DHRS4 gene cluster in mice, chimpanzees, and humans. The CpG island data in the promoter region of the genes of interest was collected from the UCSC Genome browser (http://www.genome.ucsc.edu), which defined the CpG islands as being >500 bp long, containing >55% GC-repeats and an observed CG/ expected CpG ratio of 0.65 (Takai and Jones, 2002; Zhao and Han, 2009) .
Cell lines and cell culture
The mouse liver cell line NCTC 1469, human hepatocyte cell line HL-7702, and human neuroblastoma cell lines BE(2)-M17 and SK-N-SH were obtained from the cell bank of the Chinese Academy of Sciences (Shanghai, China). The chimpanzee skin fibroblast cell line WES was obtained from American Type Cell Culture association (ATCC, Manassas, VA, USA). The human HL-7702, BE(2)-M17, and SK-N-SH, and chimpanzee WES cell lines were maintained in Dulbecco's modified Eagle's medium (DMEM) (Invitrogen, Carlsbad, CA, USA) supplemented with 10% (v/v) fetal bovine serum (Invitrogen), in a humidified 37°C incubator, containing 5% CO 2 . The mouse liver cell line NCTC 1469 was maintained in DMEM supplemented with 10% (v/v) horse serum (Invitrogen) in humidified 37°C and with 5% CO 2 .
RNA extraction and RT-qPCR
Total RNA was extracted from the mouse, chimpanzee, and human cell lines and prepared as described in a previous study (Su et al., 2010) . In short, the RNA was extracted using TRIzol ® reagent (Invitrogen) and reverse-transcribed with a QuantiTect Reverse Transcription kit (Qiagen, Venlo, Netherlands). qPCR was performed in a PRISM 7300 qPCR machine (Applied Biosystems, Foster City, CA, USA), after preparing the samples using Platinum SYBR Green qPCR SuperMix-UDG (Invitrogen). All qPCR primers are listed in Table 1 .
Bisulfite sequencing PCR for DNA methylation analysis
Genomic DNA was extracted using a QuickGene DNA tissue kit (Fujifilm, Tokyo, Japan), and the bisulfite conversion reaction was performed using an EpiTect Bisulfite kit (Qiagen, Venlo, Netherlands). PCR amplification of bisulfate-treated DNA was performed with primers listed in Table 2 ; the amplified products were then cloned and sequenced for further analysis. Table 1 . Primers used to detect RNA expression of the DHRS4 gene cluster by reverse transcriptase quantitative polymerase chain reaction (RT-qPCR). Table 2 . Primers used to detect DNA methylation in the DHRS4 gene cluster by BSP.
RESULTS AND DISCUSSION
Three homologous copies of the DHRS4 gene cluster have different expression levels
The structure of the DHRS4 gene cluster in mice, chimpanzees, and humans recorded in the GenBank database are presented in Figure 1 . Analysis of the homology between the DHRS4 genes in the reference DNA and RNA of these three mammals using BLAST indicated that the DHRS4, DHRS4L2, and DHRS4L1 genes are homologous copies in mice, chimpanzees, and humans. The mouse genome has only one copy of the DHRS4 gene. DHRS4L1 is paralogous to DHRS4 in chimpanzees and humans, while DHRS4L2, expressed only in humans, has greater homologous identity to DHRS4 than to DHRS4L1. These three species, expressing different copies of the DHRS4 gene, provide a good model for the study of the evolutionary history and expression characteristics of duplicated genes. Copying of a gene is the process of gene duplication during evolution to increase the size of the genome and its resulting proteome in biological species belonging to higher orders. Recent reports have suggested that DHRS4 modulates the metabolism of vitamin A to retinoic acid, an import molecule that influences the signal transduction affecting cell differentiation during embryo development and tumorigenesis, in rabbits (Huang and Ichikawa, 1997; Matsunaga et al., 2008; Tang and Gudas, 2011) . On the other hand, DHRS4 functions as an enzyme in pigs, dogs, and humans because of subtle differences in the substrate (Matsunaga et al., 2008; Endo et al., 2009) . Studies have indicated that, in general, genes with copy number variations coding for signal transduction, extracellular biological processes, and some metabolic pathways (such as those affecting xenobiotic compounds) are enriched in different populations (Poptsova et al., 2013) . In fact, a homologous copy of the DHRS4 gene originated as DHRS2 in species lower than the mammalian class. Unlike the DHRS4 gene, DHRS2 underwent rapid evolution, with the resulting protein reductase hep 27 presenting different substrate binding sites compared to DHRS4 (Gabrielli and Tofanelli, 2012) . Additionally, DHRS4 is a vital enzyme existing in simple species as well as humans. The evolution to primates led to the development of an additional homologous copy of DHRS4 (DHRS4L1), possibly to face the increasingly complex surroundings. This could also account for the evolution of DHRS4L2 in humans. DHRS4 gene duplication during evolution allows each species to code for a greater number of products that perform complex metabolic, or other unknown, functions.
Inherited copy number variations are known to modulate the expression of individual genes (Schlattl et al., 2011) . In this study, we analyzed the expression of the DHRS4 gene cluster with copy number variations in the mouse liver cell line NCTC 1469, chimpanzee skin fibroblast cell line WES, and human hepatocyte (HL-7702) and neuroblastoma (BE(2)-M17 and SK-N-SH) cell lines. RT-qPCR results indicated that the RNA level of DHRS4 was higher than those of DHRS4L1 and DHRS4L2 in chimpanzees and humans; on the other hand, the expression of DHRS4L1 and DHRS4L2 were lower than those of the DHRS4 gene cluster and DHRS4 and DHRS4L1, respectively (Figure 2) .
Previous studies have identified isoforms of the human DHRS4 protein (Song et al., 2007; Su et al., 2012) ; however, the proteins coded by DHRS4L2 and DHRS4L1 remain to be identified. Despite this, we did not exclude the possibility that duplicated DHRS4 genes have other undetected functions, such as the regulation of expression or function of other genes by noncoding RNA. However, this theory remains to be substantiated. In conclusion, the RNA and protein expression level of the DHRS4 gene cluster indicates that DHRS4 is the most basic and important among the tested copies of the DHRS4 gene in mammals. 
Promoter sequence and status of CpG islands could control the transcriptional activity of the DHRS4 gene cluster
Different species present different copies and varying expression levels of the DHRS4 gene cluster. In this study, we also attempted to identify the factors influencing the regulation of DHRS4 gene cluster expression by predicting the promoter activity of the DHRS4 gene cluster in mice, chimpanzees, and humans using the online platform PROSCAN.
Analysis of the gene cluster in the three species with PROSCAN led to a relatively high score for DHRS4 and DHRS4L2; that is, the score of the DHRS4L2 promoter was higher than that of DHRS4 and DHRS4L1 (lowest) in humans (Table 3) . Approximately 70% of the promoters have been correctly recognized by PROSCAN in a previous study (Prestridge, 1995) . The PROSCAN prediction attributes the low expression of DHRS4L1 RNA among the different DHRS4 copies to the long heritage distance between DHRS4 and DHRS4L2 homologous identity. Interestingly, DHRS4L2 received a high PROSCAN prediction score, despite the low DHRS4L2 RNA expression compared to that of DHRS4 in humans, indicating the role of other factors in suppressing the promoter activity of DHRS4L2.
Epigenetic regulation is a common method for the control of gene transcriptional activity without changing the DNA sequence; this includes CpG island methylation and histone modification in the promoter region. Approximately 40% of genes contain CpG islands, which are often, but not always, found in the promoter regions. The CpG island criteria (Takai and Jones, 2002) indicate that these are present in each copy of DHRS4 in chimpanzees and humans, and absent in mice. Bisulfate-treated methylation-specific PCR revealed that DHRS4L2 is hypermethylated in humans, while DHRS4 and DHRS4L1 in humans and chimpanzees are hypomethylated (Figure 3) . DNA modification by methylation is an important epigenetic mechanism that affects the spatial and temporal regulation of gene expression; in fact, promoter hypermethylation can silence the gene expression (Miranda and Jones, 2007) . Therefore, hypermethylation of the CpG islands in the DHRS4L2 promoter region could account for the high promoter score and low RNA expression of DHRS4L2 compared to DHRS4. These results are consistent with the results of previous studies, wherein the promoter regions of young duplicates are hypermethylated, whereas those of old duplicates are generally hypomethylated . This is because, as a gene that has undergone duplication for a longer period would have developed a vital function for the organism through evolution or rapid mutation, the CpG island might not even exist in this region, similar to the development of DHRS2 prior to the evolution of mammals.
On the one hand, gene duplication plays a vital role in the biological evolution of new functions and flexible regulation; on the other hand, it may also cause gene dosage imbalance, which could affect the survival or compatibility of the individual with the surroundings. Therefore, certain newly developed genes produce RNA or protein products and subsequently affect the functionality of an organism, while others simply undergo mutation and develop into pseudogenes (Rodin and Riggs, 2003) . In this study, we speculated that the duplicated DHRS4L1 has low homologous identity to DHRS4 in chimpanzees and humans. PROSCAN predicted that the transcription activity of DHRS4L1 is much lower than that of DHRS4 even without the methylation of CpG islands in DHRS4L1; this was also validated by the RT-qPCR results. DHRS4L2, which has a high homologous identity to DHRS4 in humans, showed a high PROSCAN score for promoter activity, despite the inhibition of promoter activity by DNA methylation. Copy number variations associated with genome-wide DNA methylation are accumulated in gene clusters. DNA methylation contributes to dosage rebalance during mammalian evolution after gene duplication by inhibiting the transcription of copied genes. This hypermethylation of DNA protects the duplicates from "pseudogenization" (Chang and Liao, 2012; Mendizabal et al., 2014) . However, we have been unable to predict the possible function of suppressed or active demethylated DHRS4L2. The DHRS4 gene in mice does not express any CpG islands, because of the expression of only one copy of the gene and the established role of the resulting protein in the synthesis of retinoic acid. The homologous identity and methylation status of the DHRS4 gene cluster is consistent with the theory that CpG islands are developed during the duplication of the DHRS4 gene, and that CpG island methylation potentially regulates the dose balance of copy number variation during mammalian evolution. Epigenetic mechanisms other than DNA methylation, such as histone acetylation and methylation, are also observed throughout the evolutionary tree (Simonti and Capra, 2015) ; therefore, we theorized that complex factors besides the development and methylation of CpG islands could play a role in controlling the fate of the copied DHRS4 gene cluster in mammals.
Antisense RNA might regulate the methylation of CpG islands in the DHRS4 gene cluster
With regards to the epigenetic regulation of the DHRS4 gene cluster, we have previously discovered that the natural antisense transcript of DHRS4 could mediate the DNA methylation and histone modification by recruiting DNA methyltransferases and histone methyltransferase to sense DHRS4 gene clusters in humans . Approximately 5-30% of the transcriptional units in diverse eukaryotes have been found to harbor a cis-antisense transcript. Antisense regulation is an important regulation mechanism in the human genome, with partial antisense RNA being regarded as an evolved repressor (Chen et al., 2005) . Genome-wide analyses have indicated the presence of a relationship between sense promoter methylation and antisense RNA expression; that is, the expression of a transcript from a methylated CpG island-bearing promoter has been reported to be conversely proportional to the expression of the opposite-strand transcript (Watanabe et al., 2010; Lin et al., 2013) . Knockdown of antisense RNA of the human DHRS4 gene cluster in a previous study resulted in the demethylation of DHRS4L2 CpG islands; moreover, increased RNA expression indicated the presence of an association between the expression of natural antisense transcripts and CpG islands and the evolution of DHRS4 copies, and was believed to be involved in the dosage balance of the gene cluster. PROSCAN results indicated the absence of any predicted promoter activity in the antisense strand of the mouse DHRS4 gene. The analysis predicted a potential promoter for the antisense strand for each promoter region of the DHRS4 gene cluster in human and chimpanzee genomes (Table 3) . Therefore, we speculated that, antisense transcripts could develop alongside the formation of CpG islands during evolution, in addition to the positive correlation between the CpG islands and copy number variation of DHRS4 gene cluster in mammals, resulting in their role in the regulatory mechanism (Figure 4) . In summary, our results indicate that the duplicated genes DHRS4L2 and DHRS4L1 are copied after the evolution of species to primates and humans. CpG islands and antisense transcripts are developed in the promoter region in association with gene duplication, which in turn allow for the regulation of DNA methylation and transcriptional activity, in order to balance the dosage of DHRS4 gene cluster in different species that express different copies of the DHRS4 gene cluster. However, the exact function of the duplicates, and their role in gene regulation, remains to be verified. Figure 4 . DNA methylation regulates the transcriptional activity of DHRS4 copy genes in mammalian evolution, mediated by antisense RNA. Promoter activity prediction indicates that the activity of the DHRS4L2 promoter is greater than that of DHRS4 in humans. On the other hand, the RNA expression level (detected by RT-qPCR) of DHRS4L2 is relatively lower than that of DHRS4. The CpG islands in DHRS4 and DHRS4L1 were hypomethylated, while those in DHRS4L2 were hypermethylated.
